Skip to main content

Swift Biosciences Amplicon HS Panels

Swift Biosciences has announced the early-access availability of its Swift Amplicon HS Panels, a high-sensitivity targeted amplicon library preparation kit for next-generation sequencing of liquid biopsy samples, including cell-free DNA. According to the firm, the panels allow detection and validation of mutations occurring at 0.25 percent to 3 percent frequency among a background of host samples.

The first kit being made available is Swift's EGFR Pathway Panel, which covers clinically relevant oncology hotspots including EGFR T790, KRAS G12/G13, NRAS Q61, and BRAF V600. The firm is also building custom panels and aims to release a Sample_ID panel for fetal/maternal tracing with the same sensitivity and specificity capability.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.